Organization | Siriraj Hospital

Siriraj Hospital Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Bangkok Thailand (1888)

Organization Overview

First Clinical Trial

2003

NCT01068054

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Deaprt ment of Anesthesiology ,Faculty of Medicine, Siriraj Hospital | Department of Anesthesia, Faculty of Medicine Siriraj Hospital | Department of Anesthesiology, Faculty of Medicine Siriraj Hospital | Department of Dermatology, Siriraj Hospital | Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj hospital | Department of Rehabilitation Medicine, Faculty of Medicine Siriraj Hospital | Dept of Anesthesiology, Faculty of Medicine Siriraj Hospital | Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Siriraj Hospital, Bangkoknoi, Bangkok, Thailand | Faculty of medicine Siriraj Hospital | Faculty of Medicine Siriraj Hospital | Infectious disease and tropical medicine, Siriraj hospital | Pinyo Rattanaumpawan | Reproductive medicine unit, Department of OB-GYN, Faculty of Medicine, Siriraj Hospital | Siriraj clinical research center | Siriraj Hospital | Siriraj Hospital Bangkok, Thailand | Thailand: Faculty of Medicine Siriraj Hospital

Active Ingredients

Drugs in Phase 4 Trials (25)

aripiprazole (abilify) (1 trial)

clobetasol (dermovate) (2 trials)

cyclophosphamide (cytoxan) (2 trials)

ertapenem (invanz) (1 trial)

hepatitis a vaccine, inactivated (vaqta) (1 trial)

imipenem (primaxin) (1 trial)

levobupivacaine (chirocaine) (6 trials)

lidocaine (xylocaine) (3 trials)

live attenuated chimeric japanese encephalitis vaccine (1 trial)

meropenem (merrem) (1 trial)

methadone (methadose) (1 trial)

mometasone (elocon) (1 trial)

morphine (7 trials)

polymyxin b sulfate (poly-rx) (1 trial)

povidone-iodine (1 trial)

ranibizumab (lucentis) (1 trial)

risedronate (actonel) (1 trial)

sodium chloride (2 trials)

sodium citrate (1 trial)

tacrolimus (prograf) (3 trials)

testosterone (delatestryl) (1 trial)

tigecycline (tygacil) (1 trial)

triamcinolone (kenalog) (2 trials)

valproic acid (depakene) (1 trial)

vancomycin (Vancocin) (1 trial)

Drugs in Phase 3 Trials (18)

acetylcysteine (mucomyst) (1 trial)

b1-6-12 (2 trials)

colistin (5 trials)

cyclosporine (sandimmune) (1 trial)

derris scandens benth extracts (1 trial)

desoximetasone (topicort) (1 trial)

fluticasone (cutivate) (2 trials)

fosfomycin (monurol) (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

naproxen (naprosyn) (1 trial)

oseltamivir (tamiflu) (1 trial)

rifampin (1 trial)

rimabotulinumtoxinB (Myobloc) (2 trials)

salmeterol (serevent) (1 trial)

simvastatin (zocor) (3 trials)

thiamine (1 trial)

vitamin c (1 trial)

Drugs in Phase 2 Trials (16)

alemtuzumab (campath) (1 trial)

choleragarde (1 trial)

cytokine induced killer cells (1 trial)

doxorubicin (Doxil) (1 trial)

epinephrine (levophed) (2 trials)

ibritumomab tiuxetan (zevalin) (1 trial)

ivermectin (stromectol) (1 trial)

lamivudine (epivir) (1 trial)

minoxidil (loniten) (1 trial)

mucosal cell (1 trial)

nevirapine (viramune) (1 trial)

prednisone (meticorten) (1 trial)

sodium 2,2-dimethylbutyrate (1 trial)

vincristine (oncovin) (1 trial)

zidovudine (retrovir) (1 trial)

Drugs in Phase 1 Trials (2)

ppdpsc18 (1 trial)

vm-1500 (1 trial)

Drugs in Other Trials (16)

acetazolamide (diamox) (1 trial)

aflibercept (zaltrap) (1 trial)

azithromycin (zithromax) (1 trial)

bupivacaine (Exparel) (3 trials)

colloid (1 trial)

crystalloid (1 trial)

dexmedetomidine (precedex) (1 trial)

ephedrine (1 trial)

mefenamic acid (ponstel) (1 trial)

metoclopramide (reglan) (1 trial)

mycophenolate (myfortic) (1 trial)

norepinephrine (levophed) (1 trial)

ondansetron (zofran) (1 trial)

propofol (diprivan) (1 trial)

scopolamine (transderm scop) (1 trial)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Alopecia (Phase 3)

Alopecia Areata (Phase 3)

Arteriovenous Fistula (Phase 4)

Asthma (Phase 3)

beta-Thalassemia (Phase 2)

Bipolar Disorder (Phase 4)

Calculi (Phase 4)

Cholangiocarcinoma (Phase 2)

Cholera (Phase 2)

Chronic Pain (Phase 4)

Communicable Diseases (Phase 4)

Conjunctivitis (Phase 4)

Conjunctivitis, Allergic (Phase 3)

Conjunctivitis, Viral (Phase 4)

Cross Infection (Phase 4)

Dengue (Phase 2)

Diarrhea (Phase 2)

Encephalitis (Phase 4)

Erectile Dysfunction (Phase 4)

Femoral Neck Fractures (Phase 4)

Fistula (Phase 4)

Fractures, Bone (Phase 4)

Glaucoma (Phase 4)

Glaucoma, Neovascular (Phase 4)

Healthcare-Associated Pneumonia (Phase 3)

Heart Diseases (Phase 3)

Hemorrhagic Fevers, Viral (Phase 2)

Hepatitis (Phase 3)

Hepatitis A (Phase 3)

Hepatitis B (Phase 1)

Hepatitis B, Chronic (Phase 1)

Hepatitis C (Phase 3)

Hepatitis C, Chronic (Phase 3)

Hepatitis, Chronic (Phase 1)

HIV Infections (Phase 2)

HIV Seropositivity (Phase 2)

Hypogonadism (Phase 4)

Infections (Phase 4)

Influenza, Human (Phase 3)

Injection Site Reaction (Phase 2)

Joint Diseases (Phase 4)

Keratoconjunctivitis (Phase 4)

Kidney Calculi (Phase 4)

Lung Diseases (Phase 4)

Lung Diseases, Obstructive (Phase 3)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Lymphoma, T-Cell (Phase 2)

Lymphoma, T-Cell, Peripheral (Phase 2)

Nephrolithiasis (Phase 4)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Osteoporotic Fractures (Phase 4)

Pain, Postoperative (Phase 4)

Pneumonia (Phase 3)

Psoriasis (Phase 3)

Pulmonary Disease, Chronic Obstructive (Phase 3)

Renal Insufficiency (Phase 4)

Respiratory Tract Infections (Phase 3)

Severe Dengue (Phase 2)

Staphylococcal Infections (Phase 4)

Thalassemia (Phase 2)

Vibrio Infections (Phase 2)

Vitiligo (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 74
# of Trial APIs: 77